Text Messaging Support for HIV
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to identify the most effective and cost-efficient methods to help transgender women living with HIV manage their health. It tests three approaches: one group receives support through text messages ("Text Me, Alexis!"), another through peer health navigation (one-on-one guidance), and the last group receives both. Ideal participants are transgender women diagnosed with HIV who have not recently visited an HIV care clinic, are not currently taking HIV medication, or have difficulty consistently taking their medication. Participants must be able to receive daily text messages on their phone or email. As an unphased trial, this study provides a unique opportunity to contribute to innovative strategies for improving health management.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on supporting HIV care through text messaging and peer navigation, so it's likely you can continue your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that text messaging programs like "Text Me, Alexis!" are generally safe and well-received. Studies on similar programs, such as "Text Me, Girl!", found them effective in improving HIV care without significant side effects. Participants receive daily text messages about HIV care and support, and users have responded positively to this approach.
For the Peer Health Navigation (PHN) component, research has proven it safe and effective. Previous studies have demonstrated that PHN helps people stay engaged in HIV care and adhere to their medication without negative effects. Combining PHN with text messaging has also been studied, yielding positive results in supporting people with HIV.
Overall, both the text messaging and peer navigation components have proven safe based on past use in similar situations.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they offer innovative support methods for managing HIV. Unlike standard antiretroviral therapies that focus solely on medication, "Text Me, Alexis!" uses daily text messaging to provide encouragement, education, and reminders, helping people stay on track with their care. The PHN and SMS combination adds a personalized touch with peer health navigation, addressing individual barriers and providing tailored support. This approach leverages technology and human connection, aiming to improve adherence and overall health outcomes for people living with HIV.
What evidence suggests that this trial's treatments could be effective for advancing trans women living with HIV to full viral suppression?
Research has shown that text messaging can significantly assist people living with HIV. Studies have found that sending text messages improves medication adherence and helps lower viral loads. In this trial, participants in the "Text Me, Alexis!" program will receive daily motivational and educational texts, which have shown promise in helping young trans women with HIV remain engaged in their care.
Another group in this trial will receive Peer Health Navigation (PHN), which has proven effective in maintaining low viral levels by offering personalized support. Peer navigators help overcome personal challenges to care, keeping individuals on track with their treatment plans.
A third group will receive a combination of PHN and text messaging, potentially offering the best of both approaches. This combination might enhance medication adherence and reduce viral levels by providing both personal support and regular text reminders.12678Who Is on the Research Team?
Cathy J Reback, PhD
Principal Investigator
Friends Research Institute, Inc.
Sean M Murphy, PhD
Principal Investigator
Weill Medical College of Cornell University
Are You a Good Fit for This Trial?
This trial is for trans women living with HIV/AIDS. Participants should be interested in interventions aimed at achieving full viral suppression. The study excludes individuals who do not meet the inclusion criteria set by the researchers, which are not specified here.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Peer Health Navigation (PHN), SMS text messaging, or a combination of both for 90 days
Follow-up
Participants are monitored for safety and effectiveness after treatment with assessments at 3, 6, 12, and 18 months post-enrollment
What Are the Treatments Tested in This Trial?
Interventions
- Text Me, Alexis!
Find a Clinic Near You
Who Is Running the Clinical Trial?
Friends Research Institute, Inc.
Lead Sponsor
Weill Medical College of Cornell University
Collaborator